To experimentally verify the transcriptional effect of VMR on metabolic genes in the context of thyroid carcinomas, we evaluated if PLX4032—a VMR analogue—could repress the expression of glycolysis-related genes in a BRAF-mutated PTC cell line. Here, BRAF is linked to thyroid gland carcinoma.